In vertebrate embryos, positioning of the boundary between the midbrain and hindbrain (MHB) and subsequent isthmus formation are dependent upon the interaction between the Otx2 and Gbx genes. In zebrafish, sequential expression of gbx1 and gbx2 in the anterior hindbrain contributes to this process, whereas in mouse embryos, a single Gbx gene (Gbx2) is responsible for MHB development. In the present study, to investigate the regulatory mechanism of gbx2 in the MHB/isthmic region of zebrafish embryos, we cloned the gene and showed that its organization is conserved among different vertebrates. Promoter analyses revealed three enhancers that direct reporter gene expression after the end of epiboly in the anterior-most hindbrain, which is a feature of the zebrafish gbx2 gene. One of the enhancers is located upstream of gbx2 (AMH1), while the other two enhancers are located downstream of gbx2 (AMH2 and AMH3). Detailed analysis of the AMH1 enhancer showed that it directs expression in the rhombomere 1 (r1) region and the dorsal thalamus, as has been shown for gbx2, whereas no expression was induced by the AMH1 enhancer in other embryonic regions in which gbx2 is expressed. The AMH1 enhancer is composed of multiple regulatory subregions that share the same spatial specificity. The most active of the regulatory subregions is a 291-bp region that contains at least two Pax2-binding sites, both of which are necessary for the function of the main component (PB1-A region) of the AMH1 enhancer. In accordance with these results, enhancer activity in the PB1-A region, as well as gbx2 expression in r1, was missing in no isthmus mutant embryos that lacked functional pax2a. In addition, we identified an upstream conserved sequence of 227 bp that suppresses the enhancer activity of AMH1. Taken together, these findings suggest that gbx2 expression during the somitogenesis stage in zebrafish is regulated by a complex mechanism involving Pax2 as well as activators and suppressors in the regions flanking the gene.
Introduction
One of the most important events in the early phase of brain formation in vertebrate embryos is regionalization of the preformed neural plate during gastrulation. This process is dependent upon the formation of local signaling centers that pattern the adjacent brain regions by emitting signals that affect the growth, differentiation, and morphogenesis of the local neural epithelium (Rubenstein and Beachy, 1998; Rhinn and Brand, 2001; Maves et al., 2002) . The isthmic organizer, which is among the most well studied local centers in the early brain primordia, forms at the boundary between the prospective midbrain and hindbrain (midbrain-hindbrain boundary; MHB), and induces the development of the midbrain in the anterior neural plate and cerebellum in the hindbrain (Nakamura et al., 1986; Martinez et al., 1991 Martinez et al., , 1995 . Studies of this organizer show the involvement of a gene network composed of regulatory genes that encode transcription factors and secretory factors (Rhinn and Brand, 2001; Hidalgo-Sanchez et al., 2005) . At the late gastrula stage, when the MHB region is specified, Pax2, Wnt1, and Fgf8 are induced independently in this boundary region (establishment phase). The expression of these genes gradually becomes interdependent due to positive regulatory loop formation, and downstream genes, such as the Engrailed genes, Pax5, and Pax8, are newly induced. These genes constitute a regulatory network, thereby leading to maintenance of the MHB and promotion of its further development into the isthmic structure (maintenance phase), which emanates signaling molecules that are probably the products of Fgf8 and Wnt1 (Thomas and Capecchi, 1990; Crossley et al., 1996; Lee et al., 1997; Lekven et al., 2003) .
Studies employing embryological and genetic techniques have revealed that the establishment of the MHB at early stages depends on the interactive functions of the two homeobox genes Otx2 and Gbx2 (Katahira et al., 2000; Simeone, 2000; Garda et al., 2001; Martinez-Barbera et al., 2001) . In amniotes, Otx2 is expressed in the prospective anterior brain that will later form the forebrain and midbrain, while Gbx2 is expressed in the posterior neural plate, and together they form an overlapping expression boundary (Garda et al., 2001) . This boundary progressively sharpens, probably due to mutual suppression of the two genes, and gives rise to the MHB and isthmic structure at later stages. Gene targeting and misexpression experiments conducted for Otx2 and Gbx2 in mice strongly suggest that the suppressive interaction between the two genes is responsible for positioning of the MHB (Broccoli et al., 1999; Millet et al., 1999) .
Gbx2 expression within the neuroectoderm of mouse embryos is extensively dynamic; it is rather broad in the posterior neural plate during gastrulation, but is progressively restricted to the anterior hindbrain with the anterior boundary located around the prospective MHB, eventually becoming confined to a sharp transverse stripe region at the anterior end of the hindbrain (Wassarman et al., 1997) . Similar spatial and temporal expression patterns of Gbx2 have been observed in chick and Xenopus embryos (von Bubnoff et al., 1996; Niss and Leutz, 1998; Shamim and Mason, 1998) . Meanwhile, the situation in the zebrafish seems rather different from that in amniotes and Xenopus. At the beginning of gastrulation, gbx1 expression is initiated in the posterior neural plate in an almost complementary manner with that of otx2, which is expressed in the anterior neural plate during gastrulation (Kikuta et al., 2003; Rhinn et al., 2003) ; however, the expression of gbx1 in the anterior-most region of the hindbrain is gradually downregulated during early somitogenesis stage, and is eventually overtaken by gbx2, whose expression is initiated late in gastrulation (Kikuta et al., 2003) . The expression domain of zebrafish gbx2 is initially the anterior-most hindbrain that corresponds to the entire rhombomere 1 (r1) at the bud stage, and is gradually restricted to the anterior end of r1 throughout somitogenesis, forming a narrow ringlike domain at the MHB. This changing expression of zebrafish gbx2 in r1 resembles those observed for Gbx2 in higher vertebrates at equivalent stages.
Thus, the combined expression patterns of zebrafish gbx1/gbx2 in the hindbrain are equivalent to those of mouse Gbx2, with broad expression in the anterior hindbrain during gastrulation, and then in r1 at the somite stages. At the latter stages (somitogenesis), both amniote Gbx1 and zebrafish gbx1 are expressed similarly in the posterior hindbrain in contrast to their cognate genes (Kikuta et al., 2003; Rhinn et al., 2003 Rhinn et al., , 2004 Waters et al., 2003) ; therefore, the difference between zebrafish and amniotes seems to be in the assignment of these expression domains (and functions) to the two Gbx genes, and it is likely that the regulatory mechanisms of these two Gbx genes evolved separately (Kikuta et al., 2003) . The complicated situation in the vertebrate, in terms of the expression and functions of the respective Gbx genes, prompted us to examine the regulation of gbx2 in the developing zebrafish brain.
To date, enhancer analyses of several regulatory genes that are expressed in the vicinity of the MHB have been performed, mainly in mice, demonstrating that many of them are regulated by different regulatory DNA regions at early and late phases of MHB development (Pfeffer et al., 1998 (Pfeffer et al., , 2000 (Pfeffer et al., , 2002 Rowitch et al., 1998; Kurokawa et al., 2004a,b; Inoue et al., 2006) . In spite of the accumulated information about the regulatory network in the MHB, however, few studies have focused on the regulation of Gbx2 in vertebrate embryos. In the present study, to directly address the nature of the regulatory mechanism for gbx2 in zebrafish and its molecular evolution in vertebrates, we studied the genomic organization of zebrafish gbx2, and analyzed the regulation of this gene by its flanking DNA sequence through a series of gene transfer experiments. The data obtained reveal multiple enhancer elements upstream and downstream of the gene, which recapitulate the gbx2 expression in r1 of the hindbrain in zebrafish embryos. We also show that the most active regulatory subregion in the upstream enhancer harbors binding sites for Pax2 and Otx2 and both of the Pax2 binding sites are necessary for enhancer function.
Results

Genomic organization of the zebrafish gbx2 gene
A zebrafish genomic phage library (4 · 10 5 clones) was screened by hybridization with gbx2 cDNA, which led to the isolation of three positive clones (kGXG1-3; Fig. 1 ). Structural analysis revealed that the three clones together spanned a region from À5.5 kb to +13.2 kb relative to the transcriptional start site of the gbx2 gene, which was located 426 bp upstream of the translational start codon by 5 0 -RACE (Fig. 1) . In addition, a zebrafish genome PAC library (104,064 clones) was screened by PCR for the gbx2-coding sequence, yielding two positive clones. Following hybridization with the 5 0 -terminal sequence of kGXG3 (À5.5 kb to À4.9 kb), a 9.1-kb XbaI fragment that encompassed the upstream DNA from À11.9 to À2.8 kb was identified (pBS-Xb9.1). Overall, Fig. 1 . Organization of the zebrafish gbx2 gene. The dark-grey boxes represent the two exons of gbx2, and the grey boxes represent the two highly conserved sequences found in the vicinity of the gene (UCR and DCR, Fig. 7 ). The phage clones and subclone from the PAC clone for gbx2, which were obtained and analyzed in the present study, are shown as dark-grey lines at the top. The GFP constructs examined here are also shown above the diagram of the gbx2 gene, while the sub-regions that were examined for transcriptional regulatory activities are shown below. Black lines show the DNA fragments that drive expression specifically in r1 and several other gbx2-expressing embryonic regions, while the light-grey lines represent those regions that displayed poor regulatory activities. The thick black bars show the DNA fragments (UCF and DCF) that contain the conserved sequences (UCR and DCR, respectively), which were examined for their regulatory functions. the genomic DNA region from À11.9 to +13.2 kb of gbx2 was cloned (Fig. 1) .
The gene was found to be composed of a 937-bp exon and a 1172-bp exon, which encode the N-terminal 170 amino acids (aa) and C-terminal 172 aa, respectively, separated by a 1.0-kb intron ( Fig. 1 and Fig. 2 ). This genomic organization is similar to those of the human GBX2 and mouse Gbx2 (Lin et al., 1996; Chapman et al., 1997) , in which the sizes of the coding regions encoded by the first exons are 174 and 174 aa, and those by the second exons are 173 and 174 aa, respectively. The amino acid sequences around the sites where introns interrupt the coding regions in the genome were not significantly conserved (data not shown), which makes it difficult to precisely compare the intron insertion sites among the three species; however, similarities in the sizes of the N-terminal and C-terminal portions of the coding sequences suggest that the genomic organization of Gbx2 has been conserved during vertebrate evolution.
2.2. The upstream 9.1-kb DNA region drives transcription specifically in the isthmic region
We have previously shown that the zebrafish gbx2 is expressed specifically in r1 and the otic placode/vesicle from 90% epiboly, and in other embryonic regions, including the dorsal thalamus, pharyngeal arch, and tail bud, at later stages (Kikuta et al., 2003) . To elucidate the transcriptional regulation, we ligated the genomic DNA region from À5.5 kb to the 3 0 -end of the 5 0 -UTR to the egfp gene and injected this construct (GX3-EGFP; Fig. 1 ) into zebrafish embryos, but no specific EGFP expression was detected (data not shown). Meanwhile, the Xb9.1 region (À11.9 to À2.8 kb; Fig. 1 ) was fused upstream of the hsp-driven egfp gene, creating the construct Xb9.1-EGFP. The resulting EGFP expression showed spatial restrictions similar to those described above for gbx2 (i.e., mainly in r1, the anterior-ventral hindbrain, and the dorsal thalamus), both in injected embryos (transient expression; Table 1C and data not shown) and transgenic (Tg) embryos (stable expression; Fig. 3 ), although transient expression tended to be mosaic and included some ectopic expression. Two Tg lines were obtained, both of which showed essentially the same expression patterns of EGFP. EGFP expression in F1 embryos was initiated by the 4-somite stage, when relatively high expression was observed around the prospective MHB in addition to faint expression in the anterior brain ( Fig. 3A and A  0 ). At the 6-somite stage, EGFP expression was confined to the anterior-most hindbrain/r1 and anterior-ventral hindbrain ( Fig. 3B and B 0 ), and appeared in the dorsal thalamus by 26 h post-fertilization (hpf) (Fig. 3C and C 0 ; see also Fig. 3I ). Expression in the anterior-ventral hindbrain corresponded mainly to rhombomere 4 (r4) by 24 hpf. During late somitogenesis, EGFP expression was progressively confined to the anterior end of r1 (data not shown; see also Fig. 3G-I ). Essentially the same expression pattern was obtained after early somitogenesis in F2 Tg embryos, obtained by mating adult F1 pairs ( Fig. 3D-I ), although in some embryos, probably due to homozygosity of the transgene, expression was so high that additional expression was observed in the lens and unidentified cells in the dorsal trunk after the 20-somite stage ( Fig. 3G-I ). Interestingly, fluorescence was also detected in F2 embryos from the 1-cell stage to the epiboly stage without spatial specificity, probably due to maternal expression of EGFP ( Fig. 3D and E) . Since faint maternal expression was detected for gbx2 (Kikuta et al., 2003) , this maternal EGFP may also represent endogenous expression.
Although EGFP fluorescence is a convenient way to detect transgene expression in live embryos, it is well known that temporal patterns of EGFP fluorescence do not accurately reflect temporal gene regulation, since the EGFP protein is highly stable (Li et al., 1998) . Furthermore, it takes several hours for the chromophore of a nascent EGFP protein to mature in live cells (Sniegowski et al., 2005) . To circumvent these shortcomings, we examined the expression of egfp using whole-mount in situ hybridization ( Fig. 4A-H) . The expression of egfp mRNA was detected around the prospective MHB at 100% epiboly, immediately after the initiation of the endogenous gbx2 gene (Fig. 4A) ; however, in spite of this apparent similarity, the expression was more widespread than that of the endogenous gene, and weak ectopic expression was seen in the midbrain. Based on the comparison with krox20 expression in r3 at the bud stage, expression of the transgene seemed to take place in r1 (Fig. 4B) , as does the expression of gbx2 (Kikuta et al., 2003) . This expression in r1 was observed both throughout somitogenesis and thereafter, although it was gradually restricted to the anterior end of r1, like endogenous gbx2. In addition, egfp mRNA was detected in the dorsal thalamus, as was the case with EGFP ( Fig. 4F-H) , and in the tail region after 28 hpf (Fig. 4G , and data not shown). Meanwhile, egfp continued its ectopic expression in the midbrain, and another ectopic expression began at the 3-somite stage in the anterior-ventral hindbrain, which corresponded to r4, Fig. 2 . Comparison of the exon-intron organization of Gbx2 among vertebrates. The black and grey boxes show the coding sequences and untranslated regions, respectively, while the black lines represent the flanking DNA and introns. The nucleotide positions, which are shown above, are according to both the previous study (Kikuta et al., 2003) and the present study for zebrafish gbx2, and to the reported cDNA clones for mouse and human Gbx2 (Chapman et al., 1997; Lin et al., 1996) . The white numerals in the coding sequences indicate the numbers of the encoded amino acids.
as indicated by the expression of EGFP fluorescence ( Fig. 3B and B 0 ). At later stages, cells in the lens and dorsal trunk started to express mRNA of the transgene, confirming the expression of EGFP in these cells (Figs. 44D-H) . In contrast to gbx2 (Kikuta et al., 2003) , but consistent with the observation of fluorescence, no expression of egfp mRNA was observed in neural crest cells, pharyngeal arches, or neuron-like cells in the hindbrain (Fig. 4C-H) . Likewise, the transgene did not recapitulate the expression of gbx2 in the ear primordium; no reporter expression was detected at the earlier stages ( Fig. 4A-C) , while only patchy expression was seen at 24 hpf and at the later stages (Fig. 4H) .
Therefore, the expression of Xb9.1-EGFP mirrors that of gbx2 in r1 and the dorsal thalamus (and possibly in the tail).
Meanwhile, since endogenous gbx2 is not expressed in the anterior brain at early stages, or in r4, midbrain, and spinal cord at later stages, it is likely that the transgene expression observed here in these embryonic regions is incorrect.
2.3. Localization of the enhancer activity to a 1.6-kb subregion within Xb9.1
In the embryos of some animal species, regulatory DNA fragments can control the transcription of a co-injected transgene that is under the regulation of a suitable promoter (promoter-reporter) (Muller et al., 1997 (Muller et al., , 1999 DiLeone et al., 2000; Horii et al., 2003; Woolfe et al., 2005; Inoue et al., 2006) . It is likely that co-injected DNA is conjoined to promoter-reporter genes so as to form concatemers immediately after injection, leading to cis-regulation of the reporter genes (Stuart et al., 1988) . Indeed, when co-injected with hsp-EGFP DNA, in which the hsp promoter is placed upstream of the egfp gene (Fig. 1) , the Xb9.1 region drove egfp expression in a fashion similar to that seen after injection of Xb9.1-EGFP (Fig. 6B , Table 1A and C). Using this convenient method, we sought to define precisely the regulatory region within the Xb9.1 region that drives gene expression in r1, r4, and the dorsal thalamus. N.S., not scored. a Transcriptional regulatory activities were examined by co-injection with hsp-EGFP DNA into embryos, which were scored for EGFP expression at 24-28 hpf.
b Genomic DNA that were injected with hsp-EGFP. 'À' shows injection of hsp-EGFP DNA without any additional DNA. c Numbers of embryos that were injected with DNA. d Numbers of embryos that were morphologically normal after injection and examined for EGFP expression. e Numbers of embryos that showed EGFP expression. f Percentages of embryos showing regionally specific expression relative to the normal injected embryos. DT, dorsal thalamus. g GFP constructs in which EGFP expression was under regulation by the genomic DNA were injected into embryos, which were scored for EGFP expression at 24-28 hpf.
h '+' and 'À' show forward and reverse orientations, respectively, of the genomic DNA relative to the reporter gene.
Five restriction fragments from Xb9.1 (XP2.1, Ps2.3, Ps4.7, PB2.7, and BX2.0; Fig. 1 ) were co-injected with the hsp-EGFP DNA. Ps4.7 and PB2.7, both of which include the region from À7.5 to À4.8 kb, drove EGFP expression in r1, r4, and the dorsal thalamus, as did Xb9.1 (Tables 1A,B, Fig. 6C-F) . We then prepared three subfragments from the PB2.7 region by PCR (PB1-A, À7.5 to À6.8 kb; PB1-B, À6.8 to À5.9 kb; PB2, À5.9 to À4.8 kb) and examined their regulatory activities. We found that the regulatory activity of PB2.7 was carried by PB1-A and PB1-B, with PB1-A showing higher activity, while the 3 0 -terminal PB2 showed a similar but weaker regulatory function (Table 1B) . The same regulatory function was observed in embryos that were injected with constructs in which PB1-A, PB1-B, or the combined region, PB1, was ligated to hsp-EGFP in either orientation (Table 1C ). The expression of these GFP constructs was further confirmed by establishing Tg lines, wherein the expression of gbx2 in r1 and the dorsal thalamus was recapitulated as in the Xb9.1-EGFP Tg embryos (Figs. 3 J-M and Figs. 4I-K; additional data not shown). In this Tg analysis, two, three, and one lines were obtained for PB1-, PB1-A-, and PB1-B-EGFP, respectively, all of which showed essentially the same expression patterns. Based on these results, we designate the 1.6-kb PB1 region as the anterior-most hindbrain (AMH) 1 enhancer.
To further define the effective elements within the AMH1 enhancer, six subregions of PB1 DNA were prepared by PCR, and examined for their regulatory activities by co-injection with hsp-EGFP (Figs. 1, 5 ). Unexpectedly, but consistent with the fact that both PB1-A and PB1-B have similar regulatory activities, the data collectively revealed that all six subregions could direct EGFP expression in r1 in a mutually similar way, one that resembled that of the AMH1 enhancer, although their activities varied greatly ( Fig. 5 and Fig. 6G-J) . Of the fragments examined, PB1-A2 and those that contained PB1-A2 (PB1-A1/2 and -A2/A3) consistently showed high activities.
Since multiple subregions within PB1 showed similar regulatory functions in the co-injection assay, we attempted to assess the contributions of the respective subregions to the regulatory activities of PB1-A/PB1-B by deleting respective subregions from PB1-A-EGFP or PB1-B-EGFP (Figs. 5, 6M-Q 0 ) and examined EGFP expression in injected embryos. Deletion of PB1-A2 significantly reduced EGFP expression, as compared to the original construct (PB1-A-EGFP); however, deletion of PB1-A1 or PB1-A3 only partially disrupted reporter expression, and no significant reduction was observed when PB1-B1, -B2, or -B3 was removed from PB1-B-EGFP. This is in keeping with the co-injection experiment, in which all six fragments showed regulatory functions and PB1-A2 was the most effective region.
Identification of additional regulatory regions downstream of gbx2
We extended our search for regulatory regions to the downstream DNA by co-injection with hsp-EGFP ( Fig. 1 ; Supplementary data, Table S1 ), and identified additional AMH enhancer activities in the 4.8-kb SacI fragment (Sc4.8, +3.8 to +8.6 kb) and in the 4.1-kb region at the 3 0 -end of the cloned genomic DNA (Xb4.1, +9.1 to +13.2 kb). Both regions directed EGFP expression in r1, r4, and the dorsal thalamus, as was observed for the upstream AMH1 enhancer ( Fig. 6R and S) . The activity of the Sc4.8 fragment was mostly confined to the 1.3-kb DNA region from +7.3 to +8.6 kb (PS1.3; Figs. 1 and 6T). These downstream regions are referred to as the AMH2 and AMH3 enhancers, respectively, and will be further examined in another study.
Suppression of Xb9.1-driven transcription by the upstream conserved region
PipMaker analysis of the zebrafish gbx2 and mouse Gbx2 genes revealed two conserved sequences in the vicinity of gbx2 that are candidate regulatory DNA elements (Fig. 7) . In zebrafish, one is located upstream of gbx2 from À1.8 to À1.6 kb (the 227-bp upstream conserved region, UCR) and the other is located downstream from +5.1 to +5.3 kb (the 204-bp downstream conserved region, DCR). Unexpectedly, either sequences showed little regulatory function when co-injected with hsp-EGFP ( Fig. 8A and B-a and data not shown). When co-injected with Xb9.1-EGFP, however, the UCR region significantly suppressed the expression of EGFP, and the DCR region showed similar but marginally suppressive effects (Figs. 8A, B-b, and B-c).
Analysis of the transcription factors that bind to the AMH1 enhancer
The promoter analysis described above shows that, although as many as six subregions within the AMH1 enhancer direct expression in r1, PB1-A2 carries the most prominent activator function. To elucidate the upstream signals and regulatory mechanism that govern the expression of gbx2 in r1 from the end of epiboly, we examined whether this region can bind to known transcriptional regulatory factors that regulate MHB formation.
Close inspection of the 291-bp PB1-A2 sequence for potential transcription factor-binding sites revealed two potential binding sequences for Pax2 (Epstein et al., 1994) and up to five binding sites for Otx2 (Briata et al., 1999) (Fig. 9A and Fig. 10A ). To determine whether these sequences could serve as binding sites for the transcription factors, we conducted a series of EMSA experiments. We examined the abilities of different genomic fragments to compete with zebrafish Otx2 and Pax2a (Fig. 10A ), which were synthesized by in vitro transcription-translation, for binding to the OTS and BS-I reference oligos that were previously shown to bind to the Otx2 and Pax2 proteins, respectively (OTS, Briata et al., 1999; BS-I, Song et al., 1996) . Initially, we checked the competing activities of the six fragments from the PB1/AMH1 enhancer region (A1-A3, B1-B3; Fig. 1 and Fig.5 ), and found that although all the fragments showed competing activities in terms of Pax2a binding, PB1-A2 showed the strongest activity Comparison of the expression of egfp (black arrowhead) with that of krox20 in r3 (red arrowhead) by two-color in situ hybridization the bud stage shows that egfp is expressed in r1 of the hindbrain at this stage. The egfp gene is transiently expressed in the trunk regions at mid-somitogenesis stages (blue arrows), and in the tail region at pharyngula stages (bracket). Scale bars, 200 lm. Fig. 5 . Distribution of multiple regulatory activities in the AMH1 enhancer. Subregions (A1-A3 and B1-B3), which were prepared from the AMH1 enhancer (PB1) by PCR, were co-injected with hsp-EGFP into embryos (Co-inj). Alternatively, embryos were injected with PB1-A-EGFP or PB1-B-EGFP DNA, the subregions of which were internally deleted (Construct). There is an 20-bp overlapping between the adjacent subregions. The embryos were scored for EGFP expression at 24-28 hpf. The percentages of embryos that expressed EGFP in r1 relative to the numbers of injected normal embryos (n) are shown. ( Fig. 10B) . All of the fragments competed efficiently with Otx2 for binding to the OTS oligo, apart from PB1-B1, which showed only a weak competing activity (Supplementary data, Fig. S1A ). These results support the possibility that Pax2a and Otx2 are the real trans-acting factors controlling the AMH1 enhancer, and are compatible with our finding that all the six subregions possess enhancer activities, with PB1-A2 being the most effective activator.
When three subregions from PB1-A2 (A2a, A2b, and A2c) were similarly analyzed, the A2b region alone was competitive with Pax2a in binding to BS-I (Fig. 10B) , while all three regions competed efficiently for OTS binding with Otx2 (Fig. S1B) , which is consistent with the prediction of the binding sites for the two transcription factors (Fig. 9A and Fig. 10A ). Taken together, it is highly likely that major Pax2 sites in the AMH1 enhancer are located in the A2b (Schwartz et al., 2000) was used to compare the flanking DNA sequence from À20 to +20 kb of the zebrafish gbx2 with that of mouse Gbx2. Sequence blocks with 50-100% identical sequences (y-axis) are indicated, together with their positions (x-axis). Two highly conserved sequences were identified upstream and downstream of gbx2, as indicated with rectangles (UCR and DCR, respectively). (B and C) Alignment of the conserved sequences in the zebrafish (top) and mouse (bottom) genes. region, while there are multiple Otx2 sites in PB1-A2 (and probably across the AMH1 enhancer).
We next focused on the Pax2a binding sites in the PB1-A2 region. Analysis of the competing activities of oligonucleotides from PB1-A2 (P1-4), which contained binding sites for Pax2 and/or Otx2, revealed that P2 and P3 alone possessed significant competing activities for Pax2 binding (Fig. 10B) , as was expected from the location of the putative Pax2-binding sites in these two regions (Px-I, Px-II, Fig. 9B ). When base substitutions were introduced into the core Pax2-binding sites in oligos P2 and P3 (P2m and P3m, respectively), their competitive activities were disrupted significantly (Fig. 10C) , which confirms the specificities of their binding activities. The P2 and P3 oligos were shown directly to bind to Pax2a, and this binding was competed efficiently by excess amounts of BS-I and unlabeled cognate oligos (Fig. 10D) , confirming that P2 and P3 are potent Pax2-binding sequences.
Disruption of the Pax2-binding sites affects the regulatory functions of the AMH1 enhancer
To address whether Pax2 binding to the two Pax-binding sites in PB1-A2 is essential for the regulatory function of the AMH1 enhancer, base substitutions were introduced into either or both of the Pax2 binding sites in PB1-A-EGFP, and EGFP expression was examined by embryo injection (Fig. 11A) . Disruption of one or the other Pax2-binding sites drastically reduced the expression of the construct, and double disruption almost abrogated reporter expression, confirming that the two Pax2-binding sites in PB1-A2 are critical for the function of PB1-A, the major component of the AMH1 enhancer. It should be emphasized that even a single disruption in either Pax2-binding site significantly reduced the function of the enhancer.
Expression of PB1-A as well as gbx2 in zebrafish embryos depends largely on the function of pax2a
Our analysis of the regulatory mechanism strongly suggested that gbx2 expression in zebrafish embryos is dependent on pax2a that is also expressed in the vicinity of the prospective MHB. To confirm the dependence of the AMH1 enhancer on Pax2 function, we examined the expression of PB1-A-EGFP in the no isthmus (noi) genetic background, wherein the pax2a gene is disrupted , and found that EGFP expression was lost specifically in r1 (Fig. 11B) . Interestingly, expression in the dorsal thalamus and r4 was not affected at all. This shows that PB1-A function strongly depends on pax2a in embryos, as expected from the in vitro binding experiments. Finally, we examined endogenous gbx2 expression in noi mutant embryos, and found that gbx2 expression was absent specifically at the MHB both at the bud stage and at 24 hpf (Fig. 11C) . Therefore, both PB1-A function and gbx2 expression in embryonic brains require the presence of Pax2a.
Discussion
AMH1 enhancer functionality depends on the gene network that governs MHB development through the Pax2-binding sites
In amniote embryos, Gbx2 is the functional Gbx gene throughout MHB/isthmic development (Fig. 12A) . Indeed, Gbx2 is expressed in the anterior hindbrain during gastrulation and within r1 during somitogenesis, and its expression appears temporally continuous in the MHB/isthmic region. Another Gbx gene, Gbx1, is expressed in the forebrain and posterior hindbrain (Waters et al., 2003; Rhinn et al., 2004) , which makes it unlikely that amniote Gbx1 is involved in MHB formation. In contrast, in zebrafish embryos, it is gbx1 that functions as a regulator during gastrulation in MHB formation, while expression of gbx2 is initiated in the anterior hindbrain in late gastrulae (90% epiboly). The gbx2 gene seems to be the main functional Gbx gene in this region after the onset of somitogenesis, since gbx1 expression is downregulated in r1 at early somite stages in this species ( Fig. 12A ; Kikuta et al., 2003; Rhinn et al., 2003) . During somitogenesis, zebrafish gbx1 is (Czerny et al., 1993; Epstein et al., 1994) . From these published consensus sequences and the two binding sequences in the enhancer of mouse En2 (BS-I and BS-II; Song et al., 1996) , a Pax2 consensus sequence was deduced, as shown. The sequences of oligos P2 and P3 are shown below, with asterisks showing matches with the consensus sequence. The 'À' symbols show that the sequences are in the reverse orientation. In the mutant oligos, P2m and P3m, three bases were substituted as shown below the respective sequences, leading to disruption of the cores of the Pax2-binding sites. expressed in the posterior hindbrain like the amniote Gbx1 genes.
Comparison of the expression patterns of the amniote and zebrafish Gbx genes suggests that the expression of zebrafish gbx2 resembles that of the amniote Gbx2 in the maintenance phase. In zebrafish embryos, gbx2 is induced in r1 at the end of epiboly, together with the three early MHB-specific genes (pax2a, fgf8, and wnt1; Kikuta et al., 2003) ; however, gbx2 expression is abrogated by mutations in fgf8 (acerebellar, ace) and pax2a (noi; this study), showing that gbx2 lies downstream of these early MHB genes. Indeed, the gbx2-expressing region at the MHB almost coincides with or is encompassed by the expression domain of fgf8 and pax2a (Reim and Brand, 2002; Kikuta et al., 2003) . It seems likely that gbx2 functions to maintain the MHB and to promote isthmus development at later stages, in concert with other MHB genes. Therefore, it is reasonable that the AMH1 enhancer of gbx2 contains functional Pax2-binding sites and that their disruption abrogates the enhancer activity.
The data obtained in this study show that the A2b region in PB1-A2 is the major Pax2-binding region within the AMH1 enhancer, and the two Pax2-binding sites therein (Px-I and Px-II) are indispensable for the regulatory activity of the entire PB1-A enhancer, which is a major region of the AMH1 enhancer. Because disruption of one or the other of the two Pax2 binding sites significantly affected the function of the PB1-A enhancer, Px-I and Px-II may act cooperatively to regulate gbx2 expression. Since expression of pax5 and pax8 are also initiated in the MHB region as downstream genes of pax2a somewhat later during early somitogenesis (5-and 7-somite stages, respectively; Pfeffer et al., 1998; Rhinn and Brand, 2001) , and their products bind to the Pax2-binding sites (Kozmik et al., 1993) , it is probable that the two Pax2-binding sites mediate the functions of Pax5 and Pax8 as well. We further showed in the present study that the activity of the main portion of the AMH1 enhancer (PB1-A) depends on functional pax2a in vivo. Taken together, we conclude that the AMH1 enhancer is involved in the maintenance of gbx2 expression in the MHB through binding to Pax2, Pax5, and Pax8. The specific loss of gbx2 expression in the noi mutant embryos further supports the dependence of gbx2 transcription on the function of pax2a. Similarly, other MHB genes, such as Wnt1, En2, and Pax5, are also regulated by enhancers that mediate the function of Pax2/5/8 (Rowitch et al., 1998; Song et al., 1996 Song et al., , 2000 Pfeffer et al., 2000) . In addition, in ovo transfection studies in chick embryos showed that Pax2 is necessary and sufficient for the expression of Fgf8, which is an essential regulatory growth factor gene for MHB development (Okafuji et al., 1999; Ye et al., 2001) . A recent cDNA microarray analysis revealed additional Pax2 target genes that are expressed in the MHB, further confirming the pivotal role of Pax2 in MHB development (Bouchard et al., 2005) .
The domains and the temporal patterns of expression, however, are different even among the MHB-specific genes, increasing the likelihood that factors other than Pax2 regulate the expression of MHB-specific genes. In fact, although the expression domains of Gbx2 and Pax2 overlap significantly at the MHB, Pax2 expression straddles the MHB and is present in the prospective midbrain, in contrast to Gbx2 expression (Rowitch and McMahon, 1995; Lun and Brand, 1998; Hidalgo-Sanchez et al., 1999) . Direct evidence to support the possible involvement of other regulatory factors is limited at present, but it has been suggested in mice that additional homeodomain proteins, such as POU family transcription factors, are involved in the regulation of several MHB-specific genes including Pax2 (Pfeffer et al., 2002) , Pax5 (Pfeffer et al., 2000) , and PN-1 (Mihailescu et al., 1999) . In the present study, employing both sequence analyses and competition assays, we demonstrated multiple Otx2-binding sites within PB1-A2, as well as across the AMH1 enhancer. In preliminary experiments, we showed that most of the predicted Otx2 sites bind to the Otx2 protein (unpublished data). The presence of similar clusters of Otx2/Bcd-binding sites is known in other genes, and it has been shown in some cases that cluster formation is critical for the regulatory functions of the binding sites (Lebrecht et al., 2005; OchoaEspinosa et al., 2005) . In the case of gbx2, otx2 is not expressed in the gbx2-expressing region, which suggests that the cluster of Otx2-binding sites in PB1-A2 (and in the AMH1 enhancer) contributes to the suppression of gbx2 in the anterior brain. This idea is consistent with the formation of a sharp expression boundary at the MHB, as well as with the observation that Gbx2 is downregulated by misexpression of Otx2 in chick, Xenopus, and zebrafish embryos (Katahira et al., 2000; Glavic et al., 2002; Kikuta et al., 2003) . In fact, there are reports that Otx2 is a dual-function transcription factor that can work as either a transcriptional activator or a repressor, depending on the context (Isaacs et al., 1999; Morgan et al., 1999; Nakano et al., 2000) . We are now addressing the roles of Otx2 by introducing mutations into the Otx2-biniding sites and assessing their effects on the regulatory function of the PB1-A2 region.
Several studies have suggested the regulation of gbx2 by FGF signaling. In mouse embryos, Gbx2 is upregulated in the more anterior region by Fgf8b beads and by misexpression of Fgf8b driven by the Wnt1 enhancer (Liu et al., 1999) . In ovo electroporation experiments in chick embryos have also shown activation of Gbx2 in the anterior brain due to Fgf8 misexpression (Sato et al., 2001) . Furthermore, Gbx2 expression is dependent on the Ras-ERK pathway that is regulated by Fgf8 (Sato and Nakamura, 2004; -Hirano et al., 2005) . Consistent with these findings, gbx2 expression was downregulated in ace mutants of zebrafish that lack fgf8 function (Reim and Brand, 2002) . We have observed that Xb9.1-EGFP expression is abrogated in the ace genetic background (unpublished data), which suggests regulation of the AMH1 enhancer by FGF signaling, although the underlying mechanism remains to be addressed.
Suzuki
AMH enhancers are late enhancers of zebrafish gbx2 in the r1 region
The presence of separate establishment and maintenance phases in MHB development (Rhinn and Brand, 2001) suggests that the regulatory mechanisms for each of the genes are different in the two phases, even if the gene is expressed in similar brain regions. In fact, the expression of mouse Otx2, as well as several MHB-specific genes, is regulated by different early and late enhancers during the course of brain development (Kurokawa et al., 2004a,b; Rowitch et al., 1998; Song et al., 1996 Song et al., , 2000 Pfeffer et al., 2000; Picker et al., 2002) . In mouse and chick embryos, the expression domains of Gbx2 and Otx2 overlap extensively at the early stages, and, as the Gbx2 domain is progressively restricted to the anterior hindbrain, the expression of Otx2 and Gbx2 becomes exclusive, forming a sharp boundary (Garda et al., 2001) . Thus, the expression of amniote Gbx2 is reminiscent of the dynamic changes in Otx2 expression at the equivalent stages, which makes it likely that the amniote Gbx2 is also regulated by different enhancers during the development of the brain. Meanwhile, the expression of zebrafish gbx2 occurs only after the establishment of the MHB in r1, which appears to correspond to the laterstage expression of mouse Gbx2 in the brain (Kikuta et al., 2003) . These observations prompted us to assume that the zebrafish gbx2 is governed exclusively by a late enhancer(s). The data presented here are in keeping with this prediction, in that the changing expression patterns of the zebrafish gbx2 in r1 throughout somitogenesis, including the gradual restriction to the ringlike region at the anterior end of the hindbrain, is recapitulated closely by the AMH1 enhancer alone. Indeed, we have identified two additional AMH enhancers in the downstream region (AMH2 and AMH3), which show similar regulatory functions to those of the AMH1 enhancer. The physiological significance of this apparent redundancy in gbx2 regulation in zebrafish remains to be addressed.
It is noteworthy that the same genomic regions drive transgene expression in both r1 and the dorsal thalamus. The otx2 gene is expressed in the diencephalon, including the dorsal thalamus during somitogenesis, and pax6 is expressed in place of pax2/5/8 in the diencephalic region in a characteristic manner (Hauptmann and Gerster, 2000) . Since Pax6-binding sequences resemble those of Pax2 (Epstein et al., 1994) , the AMH1 enhancer may regulate expression in r1 and the dorsal thalamus through a related mechanism. In addition to the embryonic brain, gbx2 is expressed in the otic placode/otic vesicle around the end of epiboly as well as in neural crest cells and pharyngeal arches during somitogenesis (Kikuta et al., 2003) , which was not recapitulated by the regulatory regions identified in this study. The regulatory regions for these gbx2-expressing domains may be present farther upstream or downstream of the gene. Meanwhile, the regulatory regions within Xb9.1 drive expression in the telencephalon of some Tg fish lines (Figs. 3L,M) . Although not observed in our experiments (Kikuta et al., 2003) , there is a report describing the expression of zebrafish gbx2 in this brain region (Su and Meng, 2002) . Thus, it is possible that the telencephalic expression of gbx2 is transient and difficult to detect, and was observed in this study due to the stable nature of EGFP.
A highly conserved upstream sequence suppresses the function of the AMH1 enhancer
Recent data suggest that highly conserved non-coding genomic sequences can work as cis-regulatory regions for Fig. 12 . Possible molecular evolution of the regulatory mechanism for vertebrate Gbx genes as explained by the DDC model. (A) Summary of the expression of Gbx1 and Gbx2 in the isthmic region during vertebrate development. (B) The putative ancestral Gbx gene is probably regulated in the brain by at least three separate enhancers: the first enhancer drives the transcription in the anterior hindbrain (HB) at the early stages (rectangles), the second enhancer directs the expression in r1 at later stages (circles), and the third enhancer regulates expression in other regions such as the posterior hindbrain (PHB) and forebrain (ovals). The putative enhancers are positioned arbitrarily in this scheme. After duplication of the gene during vertebrate evolution, both the early HB enhancer and late AMH enhancer were degenerated in Gbx1 but have been retained in Gbx2 in the tetrapod lineage, while they have been retained in a complementary manner in the teleost lineage in gbx1 and gbx2. The tetrapod Gbx1 was not eliminated from the genome, probably because it plays an essential role in regions in which expression is driven by the third enhancer, which seems to have been lost from Gbx2/gbx2 in all vertebrates. developmental regulatory genes (Sandelin et al., 2004; Woolfe et al., 2005) . In the present study, a comparison of genomic sequences revealed two highly conserved regions in the vicinity of gbx2 (UCR and DCR). In addition, these conserved regions are located at equivalent positions relative to the gene in the mouse genome (data not shown). Interestingly, although neither region drove reporter expression, UCR strongly suppressed the expression of EGFP driven by Xb9.1, which indicates that this region can work as a suppressor of the AMH1 enhancer. It seems likely that the DCR also has some suppressive activities toward gbx2.
To confirm the suppressive function of UCR in the original context, we co-injected Xb9.1 containing the AMH1 enhancer with GX3-EGFP (Fig. 2B) , obtaining little EGFP expression, which is apparently consistent with the presence of UCR in this GFP construct (data not shown). Unexpectedly, however, internal deletion of UCR from GX3-EGFP did not allow the construct to be activated by Xb9.1. This suggests that the proximal DNA is not a simple promoter region, but possesses other suppressive elements than UCR. Thus, it is possible that there is a mechanism that unmasks the suppressive activities, though the physiological significance of this regulatory mechanism remains to be defined. The roles of these suppressive regions should be examined in larger genomic DNA regions or even in the nucleus. One possibility is that they may be required for the establishment of the proper higherorder structures or epigenetic conditions required for precise expression of gbx2 in embryonic cells. In this regard, it is worthy of note that the activities of the AMH enhancers in the midbrain, r4, and lens appear to be ectopic, and mechanisms likely exist that suppress these ectopic activities.
3.4. Differences in the expression patterns and roles of the zebrafish and mouse Gbx genes may be explained by the DDC model The molecular evolution of duplicated genes during the diversification of animals is a challenging issue in terms of understanding animal evolution (Prince and Pickett, 2002) . Classical models predict two fates for duplicated genes: non-functionalization, in which one of the two genes degenerates to a pseudogene or is lost from the genome, and neo-functionalization, in which mutations in one of the duplicated genes generate a new advantageous allele. Although the second fate is considered to be rare, the genomes of extant animals contain many duplicated genes (Nadeau and Sankoff, 1997 ). An alternative fate for the duplicates that can account for this paradox is sub-functionalization, in which the two duplicate genes are subject to complementary loss-of-function mutations after duplication in independent sub-functions. One model that can reasonably describe this process is the duplication-degeneration-complementation (DDC) model, which relies on complementary degenerative mutations in a pair of duplicated genes. In this model, the two genes together give rise to the full complement of all the functions of the single ancestral gene (Prince and Pickett, 2002) . Since eukaryotic enhancers assume modular structures, sub-functionalization of duplicated genes could occur at the level of gene regulation.
It is likely that the evolution of Gbx genes in vertebrates has undergone sub-functionalization through complementary changes in their regulatory mechanism. As discussed above, the combined expression patterns of Gbx genes in the embryonic brain are highly similar throughout this animal group, i.e., in the anterior hindbrain during gastrulation and in r1 and the posterior hindbrain during the segmentation stages. However, these expression domains and associated functions were assigned in different ways to the duplicated Gbx genes along the lineages of the amniote and teleost (Fig. 12A) . In this regard, it should be emphasized that the activities of the two gene products are very similar with respect to brain formation (Kikuta et al., 2003) . Although Gbx1 has not been reported in lower tetrapods, we favor the view that the situation in terms of the Gbx genes is similar to that in amniotes, since the expression of Xenopus Xgbx-2 is similar to that of the amniote Gbx2 (von Bubnoff et al., 1996) .
In the present study, we identified the late enhancers of zebrafish gbx2 that function in r1 during somitogenesis. We assume that sub-functionalization of the duplicated gbx genes took place at the transcriptional level, as can be explained using the DDC model. According to this model (Fig. 12B) , the ancestral Gbx gene in the common ancestor of vertebrates possessed both the early enhancer and late enhancer for anterior-hindbrain expression. It is also likely that the ancestral Gbx was regulated by an additional enhancer(s) that drove the expression in the posterior hindbrain, as is known for Gbx1 in both tetrapods and zebrafish. Under this hypothesis, after duplication of the ancestral gene, the late posterior-hindbrain enhancer was disrupted in Gbx2 but was retained in Gbx1 for all the vertebrates, while an early hindbrain enhancer and a late AMH enhancer were disrupted in a complementary but different manner in the two vertebrate lineages. Thus, the late AMH enhancer(s) has been retained in Gbx2, but has been lost in Gbx1, of both lineages, while the early hindbrain enhancer has been retained in tetrapod Gbx2, but has been disrupted in gbx2 of only the teleost lineage. As a result, Gbx1 lost its functions in MHB development in tetrapods, but has been retained in the genome because of its role in the posterior hindbrain and forebrain. This model can account for the fact that the combined expression of Gbx is similar throughout extant vertebrates, whereas expression of the respective duplicated genes in the two lineages has deviated. This hypothesis predicts that mouse Gbx2 is regulated by early and late hindbrain enhancers that correspond to the early enhancer of zebrafish gbx1 and late enhancers of zebrafish gbx2, respectively. In order to test this possibility, careful combined analyses of the sequences and regulatory functions of the flanking DNA regions of Gbx2/gbx2 from teleosts and tetrapods will be required.
To date, a single Gbx gene has been identified in Drosophila (Unplugged), and a similar role has been suggested for this gene in the boundary formation of the brain (Hirth et al., 2003) . Though Gbx genes appear to have been lost in the genome of the ascidian (Wada et al., 2003) , Gbx-like genes have been identified in the sea urchin, Anthocidaris (unpublished data), and a cephalochordate, Branchiostoma (ABD85192). It is likely that duplication of the Gbx gene took place together with the two-round genome-wide duplication that is associated with vertebrate evolution (Aparicio, 2000) , since our molecular phylogenetic analysis of the Gbx genes suggests that generation of Gbx1 and Gbx2 occurred only in the vertebrate lineage (data not shown). It should be noted in terms of the model of Gbx/gbx evolution that, although teleosts have undergone additional genomewide duplication, our searches of the genome and EST databases revealed single copies of gbx1 and gbx2 in both zebrafish and another teleost, medaka (data not shown). This finding suggests subsequent gene losses after the last genome duplication in teleosts. It will be interesting to examine the regulatory mechanism of the Gbx gene in cephalochordate embryos that have not undergone the two-round genome duplication that gave rise to vertebrates.
Experimental procedures
Animals
Adult zebrafish were maintained at 27°C under a 14-h light/10-h dark cycle. Embryos were incubated at 28.5°C until the appropriate stages. Morphological features, as well as hours post-fertilization (hpf) were used to stage the embryos (Kimmel et al., 1995) . When necessary, 0.2 mM phenylthiourea (Nakarai) was added to the culture to prevent pigment formation.
Cloning of gbx2 genomic DNA
Screening of the zebrafish genomic phage library (kFIX II; kindly donated by Dr. Okamoto, RIKEN) was performed by plaque hybridization using the gbx2 cDNA as a probe (Kikuta et al., 2003) . In order to clone large fragments of the DNA flanking gbx2, the zebrafish genomic PAC library (BUSM-1, created by Dr. C. Amemiya) was screened by PCR using the following primer pair designed for exon 1 of gbx2: 5 0 -AT GTTCATGCCATACCGGTCAGTG-3 0 and 5 0 -TAACGTGGCCAT TAGCGTGGATGT-3 0 . Two positive PAC clones were identified, and the 9.1-kb XbaI fragment (Xb9.1) from one of the positive clones (188-7C), which hybridized with the 5 0 -terminal DNA of kGX3 (À5.5 to À4.9 kb; positions referred to in the text are relative to the transcriptional start site), was subcloned into pBluescript SK-(pBS-Xb9.1, Fig. 1 ).
Determination of the transcriptional initiation site
Total RNA was purified from 24-hpf embryos as described previously (Chomczynski and Sacchi, 1987) , and subjected to 5 0 -rapid amplification of cDNA ends using the 5 0 RACE system for rapid amplification of cDNA ends (Gibco-BRL) according to the manufacturer's protocol. Briefly, cDNA was obtained from the purified total RNA using the GSP1 primer (5 0 -CTTCTTCCTCGATTCAGAGC-3 0 ). The cDNA was amplified by nested PCR using two gene-specific primers: GSP2, 5 0 -AGAGCGAGAC AAGTGCATTG-3 0 ; and GSP3, 5 0 -CGAAAACACAGACAACTCCCTG G-3 0 . The 5 0 -RACE product was subcloned into pBluescript SK-and subjected to sequencing.
Plasmid construction
The flanking DNA of gbx2 from À5.5 to +426 was amplified by PCR using LA Taq polymerase (Takara), and the amplified product was ligated into pEGFP-1 (Clontech), at the KpnI-SmaI site immediately upstream to the reporter gene (pGX3-EGFP, Fig. 1 ). The upstream DNA (Xb9.1) or fragments derived from this region (PB1, PB1-A, PB1-B) were excised from or amplified by LA-PCR from pBS-Xb9.1, and were inserted upstream of the heat shock promoter (hsp) of pZFHSP70/4-EGFP-pA (kindly provided by Dr. H. Sasaki) (Fig. 1) , in which the transcription of the egfp gene is under the control of the hsp70 promoter (Halloran et al., 2000) .
Introduction of internal deletions or base substitutions into GFP constructs
The DNA sequences of GFP constructs of interest were amplified by LA-PCR using oppositely oriented 5 0 -phosphorylated primers that flanked the target sequences to be deleted. The PCR products were self-ligated so that the flanked regions were deleted in the constructs. Site-directed base substitutions were introduced into one of the GFP constructs (PB1-A-EGFP; Figs. 1 and 11A) using the Transformer Site-Directed Mutagenesis Kit (Clontech), whereby two mutated oligonucleotides (oligos), which were also used in EMSA (P2m and P3m, Fig. 9 ), were used as mutagenic primers. The sequences of the mutated constructs were confirmed by sequencing.
Microinjection
Plasmid DNA for injection, purified using the Qiagen Plasmid Mini Kit (Qiagen), was linearized with the appropriate restriction enzymes, extracted with phenol-chloroform, and precipitated with ethanol. The DNA was solubilized in sterile water and pressure-injected into 1-cell-stage embryos, which were allowed to develop to the appropriate stages in the presence of 10 U/ml penicillin G and streptomycin (Gibco-BRL). Embryos injected with GFP constructs were examined for the expression of EGFP using a fluorescence stereomicroscope equipped with a GFP2 filter (MZ FLIII, Leica) .
In order to determine the regulatory activities of a number of genomic DNA fragments, 3-to 5-fold molar excesses of the respective genomic DNA were co-injected with linearized pZFHSP70/4-EGFP-pA DNA (hsp-EGFP, 10 pg/embryo). Injection of hsp-EGFP DNA of this amount alone gave rise to negligible expression in embryos (Tables 1A and B , Fig. 5 and Fig. 6A ). DNA fragments for co-injection were excised from plasmid DNA or obtained by PCR, fractionated by agarose gel electrophoresis, and extracted from the gel using the Qiaex II Gel Extraction Kit (Qiagen).
Establishment of transgenic lines
Plasmid constructs were linearized and introduced into embryos (10 pg/embryo). The embryos that expressed EGFP fluorescence around 24 hpf were allowed to develop further to maturation. Founder transgenic fish (Tg fish, F0) that harbored the constructs in their germ lines were identified by EGFP fluorescence in their offspring embryos. To obtain embryos homozygous for the GFP constructs, the offspring (F1) from founders that showed EGFP fluorescence were selected, raised to maturity, and mutually crossed, to generate F2 fish.
In order to introduce the PB1-A-EGFP transgene into the noi genetic background, PB1-A-EGFP Tg fish were mated with noi heterozygous fish, and the embryos with EGFP fluorescence were raised to maturity. The adult fish obtained were again mated with noi heterozygote fish, generating noi homozygotes and heterozygotes with the transgene.
Analysis of highly conserved sequences in the flanking DNA
The genomic sequences of mouse Gbx2 and zebrafish gbx2 were obtained from Ensembl Genome Data Resources (Sanger Center/Wellcome Trust, http://www.ensembl.org/), and compared using the PipMaker program; http://pipmaker.bx.psu.edu/pipmaker/. Two DNA fragments (UCF and DCF) containing the highly conserved sequences (UCR and DCR, respectively) were amplified using the following primer pairs; for UCR, 5 0 -AGAACGCCTGTCAGTGTTTC-3 0 and 5 0 -CCTTCCTT CCCTTGTTGCAC-3 0 ; and for DCR, 5 0 -CCTGAGCATTGCAGTAG ATC-3 0 and 5 0 -CCCTGATTACACTACTGCTC-3 0 (Fig. 1) . The amplified fragments were used in the co-injection experiments.
Whole-mount in situ hybridization
Digoxigenin (DIG)-labeled and fluorescein-labeled RNA probes were synthesized using the T3/T7 RNA polymerases (Stratagene) with the DIG RNA Labeling Mix and Fluorescein RNA Labeling Mix (Roche Diagnostic), respectively, according to the manufacturers' protocols. Single-color WMISH was performed, essentially as described previously (Kikuta et al., 2003) , and two-color in situ hybridization was performed, essentially according to Jowett (Jowett, 2001 ).
Synthesis of DNA-binding proteins by in vitro transcription and translation
The coding regions of pax2a and otx2 were isolated from the cDNA clones (Kelly and Moon, 1995; Mori et al., 1994) and subcloned into pTnT (Promega). The plasmids obtained were used to synthesize the gene products by in vitro transcription/translation using the TnT Coupled Reticulocyte Lysate Systems (Promega).
Electrophoretic mobility shift assay (EMSA)
Double-stranded oligos were labeled with DIG using terminal transferase (Roche) and used as probes. The binding reactions, 5% polyacrylamide gel electrophoresis, blotting, and detection by chemiluminescence were performed with the DIG Gel Shift Kit, 2nd Generation (Roche), according to the manufacture's protocol. Poly(dI-dC) was used as a nonspecific competitor, and the binding reaction was allowed to proceed at room temperature for 15 min. The reaction mixtures were separated by electrophoresis at 4°C on a 5% polyacrylamide gel in 0.5· TBE. Reference probes for Otx2 (OTS) and Pax2 (BS-I) were prepared as described previously (Briata et al., 1999; Song et al., 1996) . For the competition experiments, excess unlabeled double-stranded oligos or DNA fragments were added to the reaction mixtures (·100-500 molar excess).
